NSE - Delayed Quote INR

Amrutanjan Health Care Limited (AMRUTANJAN.NS)

695.75
-4.80
(-0.69%)
At close: June 13 at 3:29:54 PM GMT+5:30
Currency in INR All numbers in thousands
Download
Breakdown
TTM
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Total Revenue
4,518,163
4,518,163
4,212,305
3,782,252
4,045,460
Cost of Revenue
2,232,073
2,232,073
2,118,268
1,819,786
1,804,625
Gross Profit
2,286,090
2,286,090
2,094,037
1,962,466
2,240,835
Operating Expense
1,769,345
1,769,345
1,636,493
1,541,827
1,421,103
Operating Income
516,745
516,745
457,544
420,639
819,732
Net Non Operating Interest Income Expense
-2,192
-2,192
-1,567
115,604
105,880
Pretax Income
691,340
691,340
619,460
536,454
905,766
Tax Provision
182,993
182,993
169,734
138,105
233,877
Net Income Common Stockholders
508,347
508,347
449,726
398,349
671,889
Diluted NI Available to Com Stockholders
508,347
508,347
449,726
398,349
671,889
Basic EPS
17.58
--
15.50
13.65
23.00
Diluted EPS
17.58
--
15.50
13.63
22.98
Basic Average Shares
28,916.21
--
29,014.58
29,178.40
29,207.61
Diluted Average Shares
28,916.21
--
29,014.58
29,226.62
29,236.80
Rent Expense Supplemental
--
--
7,083
4,100
2,545
Total Expenses
4,001,418
4,001,418
3,754,761
3,361,613
3,225,728
Net Income from Continuing & Discontinued Operation
508,347
508,347
449,726
398,349
671,889
Normalized Income
508,347
508,347
449,726
400,141.40
688,029.88
Interest Income
--
--
148,049
117,830
111,699
Interest Expense
2,192
2,192
1,567
771
4,845
Net Interest Income
-2,192
-2,192
-1,567
115,604
105,880
EBIT
693,532
693,532
621,027
537,225
910,611
EBITDA
758,793
758,793
681,596
589,340
948,563
Reconciled Cost of Revenue
2,232,073
2,232,073
2,118,268
1,819,786
1,804,625
Reconciled Depreciation
65,261
65,261
60,569
52,115
37,952
Net Income from Continuing Operation Net Minority Interest
508,347
508,347
449,726
398,349
671,889
Total Unusual Items Excluding Goodwill
--
--
-7,573
-2,414
-21,762
Total Unusual Items
--
--
-7,573
-2,414
-21,762
Normalized EBITDA
758,793
758,793
681,596
591,754
970,325
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
-621.61
-5,621.12
3/31/2022 - 11/5/2009

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BAJAJHCARE.NS Bajaj HealthCare Limited
516.50
-1.89%
 
ANUHPHR.BO Anuh Pharma Limited
216.50
+0.60%
 
JAGSNPHARM.NS Jagsonpal Pharmaceuticals Limited
233.00
-0.86%
 
VENUSREM.NS Venus Remedies Limited
461.75
+3.60%
 
RPGLIFE.NS RPG Life Sciences Limited
2,345.00
+4.44%
 
ALKEM.NS Alkem Laboratories Limited
4,850.50
+0.08%
 
EMCURE.NS EMCURE PHARMACEUTICALS L
1,368.30
-0.55%
 
ABBOTINDIA.NS Abbott India Limited
31,405.00
-0.54%
 
LAURUSLABS.BO Laurus Labs Limited
666.05
-0.03%
 
JBCHEPHARM.NS J. B. Chemicals & Pharmaceuticals Limited
1,724.00
-1.22%